Evaluation of the effect of continuous infusion recombinant interleukin-2 (bioleukin) on peripheral blood leucocytes of patients with terminal malignancy.

por Oliver, R. T., Crosby, D., Nouri, A., Scott, E., Galazka, A.
Publicado 1989

The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]

por Stein, R. C., Malkovska, V., Morgan, S., Galazka, A., Aniszewski, C., Roy, S. E., Shearer, R. J., Marsden, R. A., Bevan, D., Gordon-Smith, E. C.
Publicado 1991

A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual dis...

por Gottlieb, D. J., Brenner, M. K., Heslop, H. E., Bianchi, A. C., Bello-Fernandez, C., Mehta, A. B., Newland, A. C., Galazka, A. R., Scott, E. M., Hoffbrand, A. V.
Publicado 1989